• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol Cases . Successful treatment of fulminant myocarditis due to COVID-19 in a 5-year-old girl

tetano

Editor, Senior Moderator
J Cardiol Cases


. 2023 Aug 26;28(6):233-235.
doi: 10.1016/j.jccase.2023.08.009. eCollection 2023 Dec. Successful treatment of fulminant myocarditis due to COVID-19 in a 5-year-old girl

Maki Nakamura[SUP] 1 [/SUP], Atsushi Kitagawa[SUP] 1 [/SUP], Yuhei Tamura[SUP] 1 [/SUP], Eri Mineo[SUP] 1 [/SUP], Manabu Takanashi[SUP] 1 [/SUP], Takashi Honda[SUP] 1 [/SUP], Fumiaki Shikata[SUP] 2 [/SUP], Yoichiro Hirata[SUP] 1 [/SUP], Kagami Miyaji[SUP] 2 [/SUP], Kenji Ishikura[SUP] 1 [/SUP]



Affiliations
Abstract

Reports of acute myocarditis are increasing due to the worldwide spread of coronavirus disease 2019 (COVID-19). We report a case of a 5-year-old girl with fulminant myocarditis caused by COVID-19, who was successfully treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The unvaccinated patient had developed fever 1 week before attending our hospital and was "presumptive positive" for COVID-19 based on the surrounding infectious situation. The fever resolved, but the day before the visit, abdominal pain appeared. The patient visited her previous physician with vomiting as the main complaint. She was transferred to our hospital due to impaired consciousness and bradycardia, with a heart rate of 40 beats/min. Immediately after transfer, she was diagnosed with complete atrioventricular (AV) block and was scheduled to undergo percutaneous pacing lead insertion. However, the patient had ventricular tachycardia, AV block and hypotension intraoperatively and required cardiopulmonary resuscitation. The patient was in an extremely unstable circulatory state, and VA-ECMO was urgently introduced. After multidisciplinary treatment for acute myocarditis, waiting for an improvement in AV block, and recovery of cardiac function, the patient was weaned from VA-ECMO on the eighth day after admission. The patient was discharged with no cardiac or neurologic sequelae.
Learning objective: The rapid introduction of veno-arterial extracorporeal membrane oxygenation for fulminant myocarditis caused by coronavirus disease 2019 (COVID-19) in young children is extremely effective. Vaccination may be important for preventing infection with COVID-19 and avoiding severe complications.

Keywords: Coronavirus disease 2019; Extracorporeal membrane oxygenation; Fulminant myocarditis.

 
Back
Top Bottom